URGN LEGAL UPDATE: A Class Action Was Filed on Behalf of UroGen Pharma Ltd. Shareholders - Contact BFA Law by The July 28 Deadli

  • NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.